Cytosorbents Crp (CTSO) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $0.73
• Market Cap: $44.63M
• EPS: $-0.18
• 52-Week High: $1.39
• 52-Week Low: $0.60

About Cytosorbents Crp

Cytosorbents Corporation (CTSO) is at the forefront of critical care immunotherapy, pioneering advanced blood purification technologies to enhance patient outcomes in severe illnesses. Utilizing its proprietary adsorbent and porous polymer technology, the company effectively removes harmful substances from the bloodstream, addressing unmet medical needs in critical care. Headquartered in Monmouth Junction, New Jersey, Cytosorbents is strategically positioned to transform treatment options for...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Cytosorbents Crp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CTSO pay dividends?

Cytosorbents Crp (CTSO) does not currently pay a regular dividend.

What is CTSO's market cap?

Cytosorbents Crp (CTSO) has a market capitalization of $44.63M with a current stock price of $0.73.